BMI1 and head and neck squamous cell carcinoma: Combination of PTC209@VNP-HA plus cisplatin significantly inhibited tumor volume and weight growth compared to the cisplatin alone, suggesting that BMI1 inhibition overcomes cisplatin resistance in HNSCC in vivo (Fig. 6d–f).